Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.65% | -8.19% | -222.79% | -37.09% | -36.60% |
| Total Depreciation and Amortization | -5.19% | -- | -9.84% | 15.35% | -15.04% |
| Total Amortization of Deferred Charges | 65.74% | -- | 82.00% | -105.49% | 16.92% |
| Total Other Non-Cash Items | 10.77% | -10.76% | 39.18% | -35.74% | 4.33% |
| Change in Net Operating Assets | -24.03% | -- | 24.78% | 25.07% | -19.62% |
| Cash from Operations | -54.53% | -22.58% | 31.46% | -20.82% | -49.20% |
| Capital Expenditure | -10.25% | 29.87% | 32.66% | 37.12% | 54.63% |
| Sale of Property, Plant, and Equipment | 746.25% | 84.68% | -82.68% | -76.43% | -86.08% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.04% | -1,516.59% | -220.08% | 90.78% | -1,716.38% |
| Cash from Investing | -9.87% | -157.63% | -91.08% | 73.77% | -1,008.14% |
| Total Debt Issued | 114.95% | -18.01% | -33.12% | 51.08% | 21.68% |
| Total Debt Repaid | -28.15% | 3.59% | 30.79% | 37.07% | -8.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 42.51% | -7.72% | -582.17% | -0.29% | 1.11% |
| Other Financing Activities | 528.80% | -590.39% | -57.37% | 70.47% | -107.69% |
| Cash from Financing | 166.48% | -47.80% | -50.72% | 99.51% | -45.14% |
| Foreign Exchange rate Adjustments | -146.49% | 156.79% | 60.69% | -75.31% | -8.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.97% | -140.49% | -28.70% | 180.34% | -522.71% |